Explore

Trendline Trendline
A2 Milk Recalls U.S. Baby Formula Due to Toxin Contamination

A2 Milk Recalls U.S. Baby Formula Due to Toxin Contamination

A2 Milk Recalls U.S. Baby Formula Due to Toxin Contamination
Rapid Read Rapid Read
FDA Issues Recall for a2 Milk Baby Formula Due to Toxin Concerns

FDA Issues Recall for a2 Milk Baby Formula Due to Toxin Concerns

The Food and Drug Administration (FDA) has announced a voluntary recall of three batches of a2 Platinum Premium USA 0-12 months baby formula by the a2 Milk Company. The recall was initiated after the detection of cereulide, a toxin produced by Bacillus cereus, during product testing. This toxin can cause food poisoning, leading to symptoms such as diarrhea, vomiting, and stomach pains. The affected batches, totaling 63,078 units, were distributed nationally through the company's website, Amazon, and Meijer stores. The formula, designed for infants up to 12 months old, was sold in 31.7oz tins with use-by dates extending into 2027. The FDA advises consumers to discard the formula or return it for a refund, and to seek medical attention if concerned about their child's health.
Rapid Read Rapid Read
The a2 Milk Company Recalls Infant Formula Due to Safety Concerns

The a2 Milk Company Recalls Infant Formula Due to Safety Concerns

The a2 Milk Company has initiated a voluntary recall of three specific batches of its infant formula. This decision was made following concerns about the safety of these products. The affected formula was distributed through Amazon and Meijer, as noted in a notice from the FDA. The recall is a precautionary measure to ensure consumer safety, although specific details about the nature of the safety concerns were not disclosed in the available information. The company is working closely with the FDA to address the issue and ensure that all affected products are removed from circulation.
Rapid Read Rapid Read
U.S. Infant Formula Supply Deemed Safe, Efforts to Enhance Cleanliness Continue

U.S. Infant Formula Supply Deemed Safe, Efforts to Enhance Cleanliness Continue

A recent government survey has found that the U.S. infant formula supply is largely free from 'forever chemicals' and other contaminants. The survey results have been discussed by health experts, including STAT reporter Sarah Todd, who emphasize the importance of maintaining and improving the safety standards of infant formula. The findings are reassuring for parents and caregivers, indicating that the current supply is safe for consumption. However, experts are advocating for further measures to ensure the cleanliness and safety of infant formula, suggesting that ongoing monitoring and improvements in manufacturing processes could enhance the quality of the product.
Rapid Read Rapid Read
a2 Milk Company Recalls Infant Formula Due to Toxin Contamination Risk

a2 Milk Company Recalls Infant Formula Due to Toxin Contamination Risk

The a2 Milk Company has voluntarily recalled three batches of its a2 Platinum Premium USA infant formula due to the presence of cereulide, a toxin produced by certain strains of the bacterium Bacillus cereus. This toxin can cause gastrointestinal issues such as nausea and vomiting. The recall affects more than 16,000 units of the formula, which is sold in 31.7-ounce tins and is intended for children aged 0 to 12 months. The affected batches have 'Use by' dates of July 15, 2026, January 21, 2027, and January 15, 2027, with specific batch numbers provided by the company. The formula was sold through the a2 Milk Company's website, Amazon, and Meijer stores. The recall was initiated after product testing, following new guidance from New Zealand's food regulatory authority, identified cereulide in the formula. No illnesses have been reported, and consumers are advised to discard the product or return it for a refund.
Rapid Read Rapid Read
USDA Issues Recall for Frozen Pizzas at Walmart and Aldi Over Salmonella Concerns

USDA Issues Recall for Frozen Pizzas at Walmart and Aldi Over Salmonella Concerns

The U.S. Department of Agriculture's Food Safety and Inspection Services has issued a public health alert for certain frozen pizzas sold at Walmart and Aldi due to potential salmonella contamination. The recall affects products containing FDA-regulated ingredients, specifically dry milk powder, which may be contaminated. The affected products include Great Value and Mama Cozzi's brand pizzas with specific lot codes and 'best if used by' dates. Consumers are advised not to consume these products, even if cooked thoroughly, and to return them to the place of purchase. No illnesses have been reported so far.
Rapid Read Rapid Read
a2 Milk Company Recalls Baby Formula Due to Toxin Risk Affecting Infants

a2 Milk Company Recalls Baby Formula Due to Toxin Risk Affecting Infants

The a2 Milk Company, a New Zealand-based dairy producer, has issued a recall for 63,078 units of its a2 Platinum Premium Infant Formula. This recall affects products sold on Amazon, in Meijer stores, and on the company's website. The recall was initiated after the discovery of cereulide toxin, produced by some strains of the bacterium Bacillus cereus, in the formula. This toxin can cause gastrointestinal symptoms such as nausea and vomiting in infants, typically developing within 30 minutes to six hours after ingestion. The recall follows new guidelines from New Zealand’s food regulatory authority. The affected products were distributed between August 27, 2025, and April 1, 2026, with importation rights expiring on December 31, 2025. No illnesses have been reported as of May 2026.
Reuters Reuters
US FDA blocked publication of COVID, shingles vaccine safety studies

US FDA blocked publication of COVID, shingles vaccine safety studies

By Padmanabhan Ananthan May 5 (Reuters) - Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the safety of widely used vaccines against COVID-19 and shingles, a Department of Health and Human Services spokesperson said.
Rapid Read Rapid Read
USDA Issues Recall for Frozen Pizzas at Walmart and Aldi Due to Salmonella Risk

USDA Issues Recall for Frozen Pizzas at Walmart and Aldi Due to Salmonella Risk

The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) has announced a recall of several frozen pizza products sold at Walmart and Aldi due to potential salmonella contamination. The recall affects various meat and poultry products that contain FDA-regulated dairy ingredients, which may be contaminated. Products include Mama Cozzi’s frozen pizzas from Aldi and Great Value’s frozen pizzas from Walmart, with specific best buy dates. The FSIS has advised consumers to discard or return these products to the place of purchase. No adverse reactions have been reported so far, but the FSIS warns that salmonella can cause serious foodborne illness.
Reuters Reuters
NZ's a2 Milk shares slump on US infant formula recall as cereulide detected

NZ's a2 Milk shares slump on US infant formula recall as cereulide detected

May 4 (Reuters) - New Zealand's a2 Milk said on Monday it was recalling three batches of its a2 Platinum infant milk formula sold in the United States after testing detected cereulide, sending its shares down nearly 14%.
Rapid Read Rapid Read
FDA Warns of Undeclared Nuts in Keto Crunch Smart Mix, Potential Allergy Risk

FDA Warns of Undeclared Nuts in Keto Crunch Smart Mix, Potential Allergy Risk

The U.S. Food and Drug Administration (FDA) has issued a warning regarding the presence of undeclared cashews, pistachios, and cherries in Second Nature Brands' Keto Crunch Smart Mix. This recall affects 10-ounce packages distributed nationwide, posing a risk to consumers with nut allergies. The issue arose from a labeling error, and while no illnesses have been reported, the recall is a precautionary measure. Consumers are advised not to consume the affected product and to contact the company for a refund.
Rapid Read Rapid Read
Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

A federal lawsuit in the U.S. District Court for the District of Columbia is challenging the legality of the Centers for Medicare & Medicaid Services' (CMS) Beneficiary Engagement Incentive (BEI) model. This program allows the furnishing of certain hemp-derived cannabinoid products to Medicare beneficiaries without U.S. Food and Drug Administration (FDA) approval. The case, Smart Approaches to Marijuana (SAM) et al. v. Robert F. Kennedy Jr. et al., questions whether CMS can introduce cannabinoid products into Medicare-connected environments without the traditional FDA approval process. Critics argue that this policy shift undermines the established sequence of science, clinical trials, FDA approval, and coverage integration, potentially signaling that clinical evidence is optional.